Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 145 (5), 1007-1015.e3
- https://doi.org/10.1053/j.gastro.2013.07.035
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2010
- Mutagenicity and Potential Carcinogenicity of Thiopurine Treatment in Patients with Inflammatory Bowel DiseaseCancer Research, 2009
- Hospitalizations for Inflammatory Bowel Disease Among US Military Veterans 1975–2006Digestive Diseases and Sciences, 2009
- Autoimmune and inflammatory disorders and risk of malignant lymphomas – an updateJournal of Internal Medicine, 2008
- Incidence and mortality from non‐Hodgkin lymphoma in Europe: The end of an epidemic?International Journal of Cancer, 2008
- Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patientsLeukemia & Lymphoma, 2008
- Risk of haematopoietic cancer in patients with inflammatory bowel diseaseGut, 2005
- Thioguanine substitution alters DNA cleavage mediated by topoisomerase IIThe FASEB Journal, 2000
- Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is lowGut, 2000
- Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reactionJournal of Medical Virology, 1992